相关实验视频

Updated: Jun 19, 2025

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

突变IDH调节恶性质瘤中抑制性髓状细胞群

Eric P Grewal^1,2, Leland G K Richardson^1,3, Jing Sun^1,3

¹Brain Tumor Immunotherapy Laboratory, Massachusetts General Hospital, Boston, Massachusetts.

Clinical cancer research : an official journal of the American Association for Cancer Research

|July 23, 2024

概括

异酸脱酶 (IDH) 基因的突变减少扩散性质瘤中的抑制性髓状细胞. 这种IDH突变效应在人体样本和临床前模型中得到证实,表明了新的治疗点.

科学领域:

神经瘤学神经瘤学
癌症免疫学癌症免疫学
分子瘤学分子瘤学

背景情况:

异酸脱酶 (IDH) 突变是扩散性质瘤的关键.
IDH突变对内髓细胞的影响在很大程度上是未知的.
以前的研究将IDH与T细胞抑制联系起来.

研究的目的:

调查IDH突变对质瘤骨髓瘤种群的影响.
在IDH-突变体与IDH-野生型质瘤中比较髓状细胞区.
使用人类标本和临床前模型.

主要方法:

人类质瘤样本的RNA测序.
患者瘤上的定量免疫光学.
同基因性小鼠质瘤模型与同基因细胞系.

主要成果:

具有IDH突变的质瘤显示出更少的抑制性髓状体特征.
在IDH突变瘤中减少了M2类巨细胞和髓质衍生抑制细胞.
突变的IDH酶引入在小鼠中重现了这些变化.

结论:

突变的IDH可以定量减少质瘤中抑制性髓状细胞.
临床前模型证实了IDH驱动的髓状细胞重编程.
已识别的骨髓状细胞群为高度质瘤提供了潜在的治疗点.

更多相关视频

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...